Best AI Tools: An Overview
The best AI tools for Health Economics and Outcomes Research (HEOR) combine domain-specific retrieval, high-recall screening, structured extraction, full audit trails, and mandatory human oversight to meet HTA and regulatory standards. Teams select tools by testing source coverage, validation metrics, traceability, and workflow fit rather than marketing claims alone. This approach mitigates risk and accelerates literature reviews and evidence packages under tight timelines.
Health economics and outcomes research faces pressure from expanding real-world data volumes, multi-country health technology assessment (HTA) requirements, and shorter submission windows. ISPOR ranked artificial intelligence as the top HEOR trend for 2026–2027, highlighting the rapid growth of generative models in systematic reviews, cohort definition, and model support. Meanwhile, guidance from HTACG, NICE, and ISPOR task forces mandates that AI must augment expert judgment while remaining fully accountable. Selecting the best AI tools for HEOR requires clear evaluation criteria rather than generic productivity claims.
Why Do HEOR Teams Need AI Tools Now?
HEOR teams need AI tools now because evidence demands are outpacing headcount, and HTA bodies have established clear conditions for acceptable AI usage. HTA serves as the formal review informing pricing and reimbursement decisions.
To understand why, three developments explain the urgency:
- Deadlines are fixed. Regulation (EU) 2021/2282 mandated the EU Joint Clinical Assessment (JCA) for new oncology medicines and advanced therapies starting January 12, 2025 (European Union, 2021). Developers have 100 days to submit the dossier after the final scope, or 60 days in accelerated cases (European Commission, 2025).
- Agencies now set rules for AI. The NICE position statement asks submitting organizations to justify AI use and states that AI should augment human involvement (NICE, 2024). In addition, the HTA Coordination Group principles keep developers fully accountable for AI-assisted dossier content (HTACG, 2026).
- Reporting standards exist. The ISPOR ELEVATE-GenAI guideline defines ten reporting domains for large language model use in HEOR (Fleurence et al., 2025).
Consequently, Generative AI Life Sciences platforms now operate inside a regulated evidence process. Tool selection is therefore a compliance decision as well as a productivity decision.
How Do AI Tools Work in an HEOR Evidence Workflow?
Five-Step AI-Enabled HEOR Evidence Workflow
An AI tool for HEOR works as a layered pipeline. It ingests sources, applies models to defined tasks, routes outputs to human reviewers, and assembles traceable deliverables. To operationalize this, the workflow follows five steps:
- Protocol setup. The team defines the PICO (population, intervention, comparator, outcome) and the eligibility criteria as structured fields.
- Search and ingestion. The platform runs date-stamped searches across bibliographic databases, trial registries, and HTA reports.
- AI-assisted screening and extraction. Models rank records against the criteria and extract study data with a confidence score and a source link.
- Human review and sign-off. A named reviewer accepts, edits, or rejects each output, and the platform logs the decision.
- Synthesis and output. The platform generates evidence tables, PRISMA flow diagrams, and draft dossier sections from the verified library.
This design keeps HEOR evidence synthesis reproducible because every figure links directly to a source passage and a reviewer decision. In contrast, standard chat assistants produce text without an auditable chain of evidence.
Which Categories of AI Tools Should HEOR Teams Compare?
HEOR teams should evaluate four tool categories based on how much of the evidence workflow each covers.
Table 1: Four categories of AI tools for HEOR evidence generation
| Category | What it does | Strength | Limitation | Best fit |
|---|---|---|---|---|
| General-purpose AI assistants | Drafts and summarizes text on request | Low cost and fast setup | No audit trail, date-stamped search, or structured extraction | Ideation and internal drafts |
| Review point tools | Prioritizes and tracks citations during screening | Mature screening workflows | Covers one stage, so data moves by export | Single reviews with a stable scope |
| End-to-end evidence platforms | Connects search, screening, extraction, synthesis, and reporting | One data model and one audit trail | Requires validation and change management | Portfolios with repeat submissions |
| Platform plus expert services | Pairs the platform with reviewers and methodologists | Added capacity and method oversight | Depends on partner quality | Teams with peak demand or thin staffing |
The best AI tools for HEOR fall into the third and fourth categories because HTA submissions require an unbroken audit trail. In addition, teams with limited capacity often employ AI-powered literature review services to ensure expert verification of all AI outputs.
How Should You Evaluate AI Tools for HEOR?
Score every candidate across seven weighted criteria, rejecting any tool that lacks traceability or robust human oversight. These criteria serve as essential gates because HTA bodies hold developers accountable for all AI-assisted outputs.
Which Criteria Separate the Best AI Tools for HEOR From General Assistants?
Seven criteria distinguish dedicated HEOR tools from general AI assistants. Teams should adjust the suggested weights to align with their specific portfolio priorities.
Table 2: Weighted evaluation matrix for AI tool selection in HEOR
| Criterion | Aspects to verify | Suggested weightage |
|---|---|---|
| Workflow fit | The tool supports your review types and dossier outputs | 15 percent |
| Validated accuracy | The vendor reports screening recall and extraction accuracy by data type | 20 percent |
| Traceability | Each data point links to a source passage and a reviewer decision | 20 percent |
| Human oversight | A named reviewer signs off on each output, with optional dual review | 15 percent |
| Disclosure reporting | The tool exports the model name, version, date, prompts, and oversight steps | 10 percent |
| Security and compliance | The vendor confirms data residency, model training policy, and copyright handling | 10 percent |
| Reuse and scalability | One evidence library serves updates, new indications, and national submissions | 10 percent |
How Should You Validate Vendor Accuracy Claims?
Validate accuracy on a completed internal review in your own therapeutic area. A review of 172 studies found that large language models extract numeric data less accurately than other data (Scherbakov et al., 2025). Therefore, ask the vendor to route numeric values to human verification by default.
Reporting quality also varies. An ISPOR Europe 2026 analysis scored 17 oncology evidence synthesis studies against the ELEVATE-GenAI checklist. The scores ranged from 50 to 83 percent, with a median of 75 percent (Singh et al., 2026). JCA teams can apply the same scoring logic when they select a JCA dossier preparation platform.
Where Do AI Tools Deliver the Most Value in HEOR?
AI tools deliver maximum value in high-volume, rules-based tasks where experts spend excessive time on manual assembly rather than analysis. Five primary use cases recur across HEOR evidence teams:
- Systematic and targeted literature reviews. The tool ranks records and pre-fills extraction forms, and reviewers verify the results.
- Living reviews. Scheduled searches keep the evidence base current between submissions.
- Value dossiers and HTA submissions. A verified evidence library feeds draft sections, which helps teams build HTA-ready evidence dossiers.
- JCA scoping. Models propose likely comparators and outcomes from earlier HTA decisions before the official scope arrives.
- Economic model inputs. Structured extraction supplies efficacy, utility, and cost inputs with a source for each value.
These use cases deliver three clear benefits: faster cycle times by automating manual tasks, consistent decision-making through uniform criteria application, and more time for experts to focus on interpretation, gap analysis, and payer strategy.
MadeAi demonstrates this capability by connecting literature review, rapid research, JCA, and dossier modules to a unified evidence base. Teams seeking to apply HEOR Evidence Synthesis with AI can adapt these five use cases to their pipeline.
What Are the Best Practices for Selecting a Tool?
Establish requirements upfront, evaluate tools on internal evidence, and integrate disclosure into everyday operations. Six practical steps guide this selection process:
- Define the evidence questions, dossier outputs, and target HTA markets before you issue a request for proposal.
- Run each vendor demo on your own asset and on one completed review.
- Measure screening recall, extraction accuracy by data type, and the reviewer edit rate.
- Write the human review rules into a standard operating procedure before go-live.
- Check the disclosure export against the NICE and HTACG expectations line by line.
- Pilot the tool on one review, and then scale it across the portfolio.
Teams without internal capacity can commission systematic literature review services for the pilot. They can then compare the AI-assisted results with the earlier manual review.
Limitations of AI in HEOR
While AI speeds up content assembly, it cannot replace clinical and methodological judgment. Teams must actively manage four key risks:
- Extraction errors. Models can omit or misread values, and numeric outcomes carry the highest risk.
- Unsupported text. Generative models can write fluent statements that no source supports, so every drafted claim needs a source link.
- Reproducibility. Model updates can change outputs, so teams must record the model version and the prompts for each run.
- Accountability. The HTACG principles keep the developer responsible for dossier content and ask teams to document each AI-assisted step (HTACG, 2026).
In addition, guidance continues to change. NICE published its statement in 2024, and the HTACG followed in 2026. Teams should therefore apply the strictest current standard across all markets and review their procedures at least once a year.
What Trends Will Shape AI Tools for HEOR Next?
Three trends will shape tool selection over the next three years:
- Submission volume will grow. The EU HTA Regulation brings orphan medicines into JCA scope in January 2028 and all remaining new medicines in 2030 (European Union, 2021).
- Reporting standards will converge. ELEVATE-GenAI and the joint position statement from Cochrane, Campbell, JBI, and the Collaboration for Environmental Evidence point toward common disclosure practice (Cochrane et al., 2025).
- Evidence bases will become living assets. Teams will maintain one indexed library per disease area and reuse it across submissions.
As a result, tool choice becomes an infrastructure decision that outlasts any single review.
Conclusion: Choose on Traceability First, Then on Speed
Finally, selecting the best AI tools for HEOR requires systematic evaluation of source coverage, validated performance metrics, audit strength, human oversight design, and workflow fit. Tools meeting these criteria accelerate systematic literature review services and HEOR Evidence Synthesis with AI, maintaining the scientific rigor HTA bodies demand. Organizations should run controlled pilots, enforce documentation standards, and retain expert oversight over all final deliverables.
Teams preparing for multi-country evidence packages can explore how purpose-built platforms support these requirements through the resources available at MadeAi.
Author’s Note: This article was supported by AI-based research and writing, with Claude 5.1 assisting in the creation of text and images.
FAQs
What are the best AI tools for HEOR?
The strongest options are purpose-built evidence platforms that connect search, screening, extraction, synthesis, and reporting on one audit trail. They link each data point to its source and record a named reviewer decision. General chat assistants do not provide those controls.
How does AI support evidence generation in HEOR?
AI ranks citations for screening, extracts study data into structured tables, and drafts dossier sections from verified evidence. Human reviewers confirm each output. The team therefore spends less time on assembly and more time on interpretation.
Do HTA bodies accept AI-assisted evidence?
HTA bodies accept AI-assisted evidence under defined conditions. NICE asks organizations to justify AI use and keep humans involved. The EU HTA Coordination Group permits AI in JCA dossier preparation, but it holds the developer fully accountable and expects documented AI-assisted steps.
Can a general-purpose AI assistant replace a dedicated HEOR platform?
A general assistant cannot replace a dedicated platform. It can draft and summarize text. However, it cannot run date-stamped searches, store structured extractions, route values to reviewers, or export an audit trail for an HTA submission.
How accurate is AI data extraction for systematic reviews?
Accuracy varies by data type and therapeutic area. Published research shows that large language models extract numeric data less accurately than other data. Teams should therefore verify numeric values manually and test each tool on a completed review.
What should an AI disclosure statement include?
A disclosure statement should name the tool, model version, date of use, and purpose. It should also list each AI-assisted step and describe the human oversight applied. Teams should retain the prompts in case an assessor requests them.
How should a team pilot an AI tool for HEOR?
Select one completed review as the benchmark. Next, run the tool on the same protocol and measure screening recall, extraction accuracy, and reviewer edit rate. Finally, compare cycle time and audit trail quality before you scale.